General and Administrative Expense of Sionna Therapeutics, Inc. from 31 Mar 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Sionna Therapeutics, Inc. quarterly and annual General and Administrative Expense in USD history and change rate from 31 Mar 2024 to 31 Dec 2025.
  • Sionna Therapeutics, Inc. General and Administrative Expense for the quarter ending 31 Dec 2025 was $8,444,000, a 118% increase year-over-year.
  • Sionna Therapeutics, Inc. General and Administrative Expense for the twelve months ending 31 Dec 2025 was $28,719,000, a 116% increase year-over-year.
  • Sionna Therapeutics, Inc. annual General and Administrative Expense for 2025 was $28,719,000, a 116% increase from 2024.
Source SEC data
View on sec.gov
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Change (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Change (%)

Sionna Therapeutics, Inc. Quarterly General and Administrative Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $28,719,000 $8,444,000 +$4,564,000 +118% 01 Oct 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 $24,155,000 $7,761,000 +$4,359,000 +128% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $19,796,000 $6,523,000 +$3,464,000 +113% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $16,332,000 $5,991,000 +$3,064,000 +105% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $13,268,000 $3,880,000 01 Oct 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q3 2024 $3,402,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $3,059,000 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $2,927,000 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1

Sionna Therapeutics, Inc. Annual General and Administrative Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $28,719,000 +$15,451,000 +116% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $13,268,000 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.